Charlotte L Zuur

Charlotte L Zuur

UNVERIFIED PROFILE

Are you Charlotte L Zuur?   Register this Author

Register author
Charlotte L Zuur

Charlotte L Zuur

Publications by authors named "Charlotte L Zuur"

Are you Charlotte L Zuur?   Register this Author

25Publications

437Reads

16Profile Views

Immuno-radiotherapy with cetuximab and avelumab for advanced stage head and neck squamous cell carcinoma: Results from a phase-I trial.

Radiother Oncol 2020 Jan 26;142:79-84. Epub 2019 Sep 26.

Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2019.08.007DOI Listing
January 2020

Disease course after the first recurrence of head and neck squamous cell carcinoma following (chemo)radiation.

Eur Arch Otorhinolaryngol 2020 Jan 10;277(1):261-268. Epub 2019 Oct 10.

Department of Radiation Oncology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-019-05676-2DOI Listing
January 2020

Organ Function Preservation Failure after (Chemo)Radiotherapy in Head and Neck Cancer: A Retrospective Cohort Analysis.

Otolaryngol Head Neck Surg 2019 08 7;161(2):288-296. Epub 2019 May 7.

1 Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0194599819846073DOI Listing
August 2019

Salvage Surgery for Recurrence after Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.

Otolaryngol Head Neck Surg 2019 06 11;160(6):1023-1033. Epub 2018 Dec 11.

1 Department of Head and Neck Oncology and Surgery, Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/0194599818818443
Publisher Site
http://dx.doi.org/10.1177/0194599818818443DOI Listing
June 2019

Salvage surgery for advanced stage head and neck squamous cell carcinoma following radiotherapy or chemoradiation.

Eur Arch Otorhinolaryngol 2019 Mar 23;276(3):647-655. Epub 2019 Jan 23.

Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00405-019-05292-0DOI Listing
March 2019

Definitive (chemo)radiotherapy is a curative alternative for standard of care in advanced stage squamous cell carcinoma of the oral cavity.

Oral Oncol 2017 12;75:163-168

Department of Head and Neck Surgery, Netherlands Cancer Institute - Antoni van Leeuwenhoek (NKI-AVL), Amsterdam, The Netherlands; Department of Oral and Maxillofacial Surgery, Academic Medical Center, University of Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S13688375173035
Publisher Site
http://dx.doi.org/10.1016/j.oraloncology.2017.11.006DOI Listing
December 2017

Identification of a novel ATM inhibitor with cancer cell specific radiosensitization activity.

Oncotarget 2017 Sep 19;8(43):73925-73937. Epub 2017 May 19.

Department of Head and Neck Oncology and Surgery, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.18034DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650312PMC
September 2017

Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.

JAMA Otolaryngol Head Neck Surg 2015 Sep;141(9):810-5

Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands3Department of Maxillofacial Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoto.2015.1515DOI Listing
September 2015

Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review.

Cancers (Basel) 2015 Aug 28;7(3):1716-42. Epub 2015 Aug 28.

Department of Head and Neck Surgery and Oncology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Plesmanlaan 121, Amsterdam 1066 CX, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers7030858DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586791PMC
August 2015

Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature.

Head Neck 2015 Feb 29;37(2):281-92. Epub 2014 Jan 29.

Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.23551DOI Listing
February 2015

Long-term hearing loss after chemoradiation in patients with head and neck cancer.

Laryngoscope 2014 Dec 26;124(12):2720-5. Epub 2014 Jun 26.

Department of Head and Neck Oncology and Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/lary.24802DOI Listing
December 2014

A new grading system for ototoxicity in adults.

Ann Otol Rhinol Laryngol 2014 Oct 12;123(10):711-8. Epub 2014 May 12.

Department of Head and Neck Oncology and Surgery, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0003489414534010DOI Listing
October 2014

Total laryngectomy for a dysfunctional larynx after (chemo)radiotherapy.

Arch Otolaryngol Head Neck Surg 2012 Jun;138(6):548-55

Departments of Head and Neck Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/archoto.2012.862DOI Listing
June 2012

No hearing loss after repeated courses of tobramycin in cystic fibrosis patients.

Acta Otolaryngol 2010 Feb;130(2):253-8

Department of Otorhinolaryngology, Head and Neck Surgery, The Netherlands Cancer Institute, 1066 CXAmsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://www.tandfonline.com/doi/full/10.3109/0001648090301515
Publisher Site
http://dx.doi.org/10.3109/00016480903015150DOI Listing
February 2010

Risk factors for hearing loss in patients treated with intensity-modulated radiotherapy for head-and-neck tumors.

Int J Radiat Oncol Biol Phys 2009 Jun 8;74(2):490-6. Epub 2009 Jan 8.

Department of Otolaryngology/Head and Neck Surgery, VU University Medical Center Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2008.08.011DOI Listing
June 2009

Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer.

Radiother Oncol 2008 Oct 14;89(1):38-43. Epub 2008 Aug 14.

Department of Head and Neck Surgery, VU University Medical Center Amsterdam, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2008.06.003DOI Listing
October 2008

Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.

Int J Radiat Oncol Biol Phys 2007 Aug 6;68(5):1320-5. Epub 2007 Apr 6.

Department of Otorhinolaryngology, Academical Medical Centre, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2007.01.042DOI Listing
August 2007